If weight is part of the treatment conversation, discuss the goal, risks, and alternatives with a licensed clinician
Another study found that people with diabetes who used Zepbound lost an average of 12% of their body weight, FDA officials said
Theyre suitable for those with type 2 diabetes requiring both glucose and weight management, patients with established cardiovascular disease benefiting from proven CV protection, and those who have achieved satisfactory results with GLP-1 therapy
Los signos y sntomas de niveles bajos de azcar en sangre pueden incluir mareos o aturdimiento, visin borrosa, ansiedad, irritabilidad o cambios de humor, sudoracin, dificultad para hablar, hambre, confusin o somnolencia, temblores, debilidad, dolor de cabeza, ritmo cardaco acelerado o sensacin de nerviosismo